local_hospital

Project Samodzielni Sp.z.o.o

Address
ul. Korotyńskiego 5/U3, 02-121 Warsaw, Poland

Project Samodzielni Sp.z.o.o - Neuromuscular Rehabilitation Research

Project Samodzielni Sp.z.o.o is a specialized medical research center focused on advancing treatments for neuromuscular disorders and rehabilitation medicine. The center demonstrates expertise in evaluating innovative therapeutic approaches for patients experiencing motor impairments following neurological injuries, with particular emphasis on spasticity management and functional recovery.

  • Lower limb spasticity treatment following stroke and traumatic brain injury
  • Botulinum toxin therapy for ankle plantar flexor involvement
  • Efficacy and safety assessment of novel neurotoxin formulations

The center's research portfolio includes rigorous evaluation of NT 201 botulinum toxin interventions, focusing on both therapeutic efficacy and patient safety outcomes. Their work specifically addresses the critical need for evidence-based treatments in adult patients with lower limb spasticity, contributing to the development of improved rehabilitation strategies and quality of life for individuals recovering from significant neurological events.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
1
IMP

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
1
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
1
Outperforms 1% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
1sponsors
Outperforms 1% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Project Samodzielni Sp.z.o.o

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety of NT 201 in Treating Lower Limb Spasticity Post-Stroke or Traumatic Brain Injury in Adults: A Randomized, Double-Blind, Placebo-Controlled StudyMerz Pharmaceuticals GmbHPhase IIINot RecruitingSep 2019

IMP list

IMP Trials Status First start Last start
Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins1Unknown2019-09-032019-09-03

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.